Antigen Loss Variants: Catching Hold of Escaping Foes

Since mid-1990s, the field of cancer immunotherapy has seen steady growth and selected immunotherapies are now a routine and preferred therapeutic option of certain malignancies. Both active and passive cancer immunotherapies exploit the fact that tumor cells express specific antigens on the cell su...

Descripción completa

Detalles Bibliográficos
Autores principales: Vyas, Maulik, Müller, Rolf, Pogge von Strandmann, Elke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323381/
https://www.ncbi.nlm.nih.gov/pubmed/28286501
http://dx.doi.org/10.3389/fimmu.2017.00175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323381/
https://www.ncbi.nlm.nih.gov/pubmed/28286501
http://dx.doi.org/10.3389/fimmu.2017.00175

Ejemplares similares